Aatmaj Healthcare Ltd.
•₹ 18.55-2.37%
2026-08-21
PROS
- Company has delivered good sales growth of 35.0% CAGR over last 5 years
- Company generates healthy free cash flow
- Company maintains a comfortable, low leverage position
CONS
- A large part of profit comes from other income (123.0% of PBT)
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.09x)
- Equity base is being diluted - shares outstanding up 737.0%
- Total debt has risen sharply - up 83.7% year on year
- Operating margins have contracted to 8.0% from 34.4%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | APOLLOHOSP | 8799.00 | 60.55 | 126516.12 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| 2. | MANIPALHOS | 744.55 | 109.75 | 97936.41 | 0.00 | — | — | — | — | 13.93 | — |
| 3. | MAXHEALTH | 996.45 | 66.57 | 96982.14 | 0.20 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| 4. | ASTERDM | 800.70 | 219.01 | 69794.81 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| 5. | FORTIS | 910.80 | 65.62 | 68761.59 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| 6. | MEDANTA | 1419.05 | 68.60 | 38154.25 | 0.04 | 157.25 | -1.09 | 1304.05 | 26.50 | 20.50 | 21.99 |
| 7. | NH | 1782.70 | 44.64 | 36431.40 | 0.25 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| 8. | KIMS | 788.60 | 162.12 | 33121.71 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| 9. | LALPATHLAB | 1886.80 | 58.44 | 31669.72 | 1.09 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| 10. | AGARWALEYE | 499.70 | 106.77 | 15841.80 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 14.32 | 27.75 |
| 11. | VIJAYA | 1489.70 | 81.84 | 15343.57 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.27 | 42.66 |
| 12. | AATMAJ | 19.00 | 8.73 | 42.94 | 0.00 | — | — | — | — | 3.39 | — |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 4 | 17 | 22 | 27 | 16 | 20 | |
| 4 | 12 | 14 | 17 | 13 | 18 | |
| Operating Profit | 1 | 5 | 8 | 10 | 3 | 3 |
| OPM % | 16 | 31 | 34 | 36 | 22 | 15 |
| Other Income | 0 | 0 | 0 | 0 | 1 | 1 |
| Interest | 1 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 |
| -0 | 4 | 7 | 8 | 1 | 1 | |
| Tax % | -52 | 8 | 26 | 29 | 34 | 40 |
| Net Profit | -0 | 4 | 5 | 6 | 1 | 1 |
| EPS | -0 | 8 | 0 | 0 | 0 | 0 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 13 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -0 | 3 | 3 | 4 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -0 | 3 | 3 | 4 | 0 | 0 |
Mar 2020
- 4
- 4
- Operating Profit
- 1
- OPM %
- 16
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- -0
- Tax %
- -52
- Net Profit
- -0
- EPS
- -0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
Mar 2021
- 17
- 12
- Operating Profit
- 5
- OPM %
- 31
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 4
- Tax %
- 8
- Net Profit
- 4
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2022
- 22
- 14
- Operating Profit
- 8
- OPM %
- 34
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 7
- Tax %
- 26
- Net Profit
- 5
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2023
- 27
- 17
- Operating Profit
- 10
- OPM %
- 36
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 8
- Tax %
- 29
- Net Profit
- 6
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2024
- 16
- 13
- Operating Profit
- 3
- OPM %
- 22
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 1
- Tax %
- 34
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2025
- 20
- 18
- Operating Profit
- 3
- OPM %
- 15
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 1
- Tax %
- 40
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 35%
- 3 Years:
- -4%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -50%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -27%
- 1 Year:
- -4%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 102%
- 3 Years:
- 19%
- Last Year:
- 1%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - |
| Equity Capital | 1 | 1 | 1 | 8 | 11 | 11 |
| -2 | 2 | 7 | 6 | 38 | 39 | |
| 1 | 0 | 4 | 10 | 4 | 8 | |
| Trade Payables | 1 | 2 | 2 | 2 | 1 | 1 |
| 8 | 4 | 3 | 5 | 3 | 3 | |
| Total Liabilities | 9 | 10 | 17 | 31 | 58 | 63 |
| ASSETS | - | - | - | - | - | - |
| 8 | 8 | 11 | 11 | 18 | 18 | |
| 0 | 0 | 0 | 0 | 1 | 1 | |
| 0 | 0 | 0 | 0 | 21 | 25 | |
| Cash & Bank | 0 | 1 | 0 | 0 | 11 | 12 |
| 1 | 1 | 6 | 19 | 7 | 8 | |
| Total Assets | 9 | 10 | 17 | 31 | 58 | 63 |
| Total Debt | 9 | 4 | 5 | 12 | 5 | 10 |
| Net Working Capital | -2 | -1 | -1 | 5 | 33 | 35 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | -6.91 | 23.62 | 61.27 | 8.75 | 21.89 | 22.18 |
| Face Value | 10.00 | 10.00 | 10.00 | 5.00 | 5.00 | 5.00 |
| Total Debt | 9 | 4 | 5 | 12 | 5 | 10 |
| Net Working Capital | -2 | -1 | -1 | 5 | 33 | 35 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | -6.91 | 23.62 | 61.27 | 8.75 | 21.89 | 22.18 |
| Face Value | 10.00 | 10.00 | 10.00 | 5.00 | 5.00 | 5.00 |
Mar 2020
- Equity Capital
- 1
- -2
- 1
- Trade Payables
- 1
- 8
- Total Liabilities
- 9
- 8
- 0
- 0
- Cash & Bank
- 0
- 1
- Total Assets
- 9
- Total Debt
- 9
- Net Working Capital
- -2
- Contingent Liabilities
- 0
- Book Value per Share
- -6.91
- Face Value
- 10.00
- Total Debt
- 9
- Net Working Capital
- -2
- Contingent Liabilities
- 0
- Book Value per Share
- -6.91
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 1
- 2
- 0
- Trade Payables
- 2
- 4
- Total Liabilities
- 10
- 8
- 0
- 0
- Cash & Bank
- 1
- 1
- Total Assets
- 10
- Total Debt
- 4
- Net Working Capital
- -1
- Contingent Liabilities
- 0
- Book Value per Share
- 23.62
- Face Value
- 10.00
- Total Debt
- 4
- Net Working Capital
- -1
- Contingent Liabilities
- 0
- Book Value per Share
- 23.62
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 1
- 7
- 4
- Trade Payables
- 2
- 3
- Total Liabilities
- 17
- 11
- 0
- 0
- Cash & Bank
- 0
- 6
- Total Assets
- 17
- Total Debt
- 5
- Net Working Capital
- -1
- Contingent Liabilities
- 0
- Book Value per Share
- 61.27
- Face Value
- 10.00
- Total Debt
- 5
- Net Working Capital
- -1
- Contingent Liabilities
- 0
- Book Value per Share
- 61.27
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 8
- 6
- 10
- Trade Payables
- 2
- 5
- Total Liabilities
- 31
- 11
- 0
- 0
- Cash & Bank
- 0
- 19
- Total Assets
- 31
- Total Debt
- 12
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 8.75
- Face Value
- 5.00
- Total Debt
- 12
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 8.75
- Face Value
- 5.00
Mar 2024
- Equity Capital
- 11
- 38
- 4
- Trade Payables
- 1
- 3
- Total Liabilities
- 58
- 18
- 1
- 21
- Cash & Bank
- 11
- 7
- Total Assets
- 58
- Total Debt
- 5
- Net Working Capital
- 33
- Contingent Liabilities
- 0
- Book Value per Share
- 21.89
- Face Value
- 5.00
- Total Debt
- 5
- Net Working Capital
- 33
- Contingent Liabilities
- 0
- Book Value per Share
- 21.89
- Face Value
- 5.00
Mar 2025
- Equity Capital
- 11
- 39
- 8
- Trade Payables
- 1
- 3
- Total Liabilities
- 63
- 18
- 1
- 25
- Cash & Bank
- 12
- 8
- Total Assets
- 63
- Total Debt
- 10
- Net Working Capital
- 35
- Contingent Liabilities
- 0
- Book Value per Share
- 22.18
- Face Value
- 5.00
- Total Debt
- 10
- Net Working Capital
- 35
- Contingent Liabilities
- 0
- Book Value per Share
- 22.18
- Face Value
- 5.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -1 | 6 | 10 | 5 | -8 | 3 | |
| Cash from Investing | -0 | -1 | -3 | -1 | -8 | -1 |
| Cash from Financing | 1 | -5 | -7 | -4 | 26 | -1 |
| -0 | 1 | -0 | 0 | 10 | 1 | |
| Free Cash Flow | -1 | 6 | 6 | 4 | -16 | 3 |
| OCF / Net Profit | 1.98 | 1.48 | 1.89 | 0.90 | -9.09 | 5.22 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | 3 |
| OCF / Net Profit | 1.98 | 1.48 | 1.89 | 0.90 | -9.09 | 5.22 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | 3 |
Mar 2020
- -1
- Cash from Investing
- -0
- Cash from Financing
- 1
- -0
- Free Cash Flow
- -1
- OCF / Net Profit
- 1.98
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.98
- Cumulative 5-Year FCF
- 0
Mar 2021
- 6
- Cash from Investing
- -1
- Cash from Financing
- -5
- 1
- Free Cash Flow
- 6
- OCF / Net Profit
- 1.48
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.48
- Cumulative 5-Year FCF
- 0
Mar 2022
- 10
- Cash from Investing
- -3
- Cash from Financing
- -7
- -0
- Free Cash Flow
- 6
- OCF / Net Profit
- 1.89
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.89
- Cumulative 5-Year FCF
- 0
Mar 2023
- 5
- Cash from Investing
- -1
- Cash from Financing
- -4
- 0
- Free Cash Flow
- 4
- OCF / Net Profit
- 0.90
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.90
- Cumulative 5-Year FCF
- 0
Mar 2024
- -8
- Cash from Investing
- -8
- Cash from Financing
- 26
- 10
- Free Cash Flow
- -16
- OCF / Net Profit
- -9.09
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -9.09
- Cumulative 5-Year FCF
- 0
Mar 2025
- 3
- Cash from Investing
- -1
- Cash from Financing
- -1
- 1
- Free Cash Flow
- 3
- OCF / Net Profit
- 5.22
- Cumulative 5-Year FCF
- 3
- OCF / Net Profit
- 5.22
- Cumulative 5-Year FCF
- 3
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - |
| EPS (₹) | -2.00 | 30.53 | 37.41 | 3.65 | 0.39 | 0.28 |
| Book Value (₹) | -6.91 | 23.62 | 61.27 | 8.75 | 21.89 | 22.18 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 |
| Cash EPS (₹) | 0.06 | 2.79 | 3.39 | 4.07 | 0.75 | 0.69 |
| PROFITABILITY | - | - | - | - | - | - |
| Operating Margin % | 15.80% | 30.66% | 34.44% | 36.29% | 16.22% | 7.98% |
| Net Margin % | -6.20% | 23.88% | 23.16% | 21.74% | 5.60% | 3.27% |
| ROE % | 0.00% | 365.56% | 88.15% | 52.62% | 2.77% | 1.28% |
| ROCE % | 4.16% | 63.84% | 67.49% | 46.63% | 6.41% | 3.39% |
| -2.90% | 43.10% | 37.04% | 24.37% | 1.99% | 1.06% | |
| EFFICIENCY | - | - | - | - | - | - |
| Debtor Days | 82 | 16 | 47 | 154 | 446 | 422 |
| Inventory Days | 12 | 4 | 5 | 5 | 12 | 13 |
| Payable Days | 498 | 121 | 166 | 394 | 255 | 204 |
| -404 | -101 | -113 | -234 | 203 | 231 | |
| FINANCIAL HEALTH | - | - | - | - | - | - |
| Debt to Equity (x) | -9.39x | 1.36x | 0.63x | 0.83x | 0.11x | 0.20x |
| Interest Coverage (x) | 0.65x | 11.06x | 29.30x | 10.24x | 2.07x | 2.21x |
| 0.41x | 0.51x | 0.83x | 1.38x | 6.43x | 4.24x | |
| GROWTH | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 296.13% | 26.36% | 24.55% | -42.06% | 24.12% |
| Operating Profit Growth % | 0.00% | 668.53% | 41.94% | 31.24% | -65.50% | -15.44% |
| Net Profit Growth % | 0.00% | 1624.94% | 22.54% | 16.94% | -85.09% | -27.42% |
| 0.00% | 0.00% | 0.00% | 0.00% | -89.31% | -27.41% | |
| VALUATION | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 80.18x | 51.96x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 1.43x | 0.66x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.16% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 19.20x | 10.82x |
Mar 2020
- EPS (₹)
- -2.00
- Book Value (₹)
- -6.91
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.06
- Operating Margin %
- 15.80%
- Net Margin %
- -6.20%
- ROE %
- 0.00%
- ROCE %
- 4.16%
- -2.90%
- Debtor Days
- 82
- Inventory Days
- 12
- Payable Days
- 498
- -404
- Debt to Equity (x)
- -9.39x
- Interest Coverage (x)
- 0.65x
- 0.41x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 30.53
- Book Value (₹)
- 23.62
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.79
- Operating Margin %
- 30.66%
- Net Margin %
- 23.88%
- ROE %
- 365.56%
- ROCE %
- 63.84%
- 43.10%
- Debtor Days
- 16
- Inventory Days
- 4
- Payable Days
- 121
- -101
- Debt to Equity (x)
- 1.36x
- Interest Coverage (x)
- 11.06x
- 0.51x
- Revenue Growth %
- 296.13%
- Operating Profit Growth %
- 668.53%
- Net Profit Growth %
- 1624.94%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 37.41
- Book Value (₹)
- 61.27
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.39
- Operating Margin %
- 34.44%
- Net Margin %
- 23.16%
- ROE %
- 88.15%
- ROCE %
- 67.49%
- 37.04%
- Debtor Days
- 47
- Inventory Days
- 5
- Payable Days
- 166
- -113
- Debt to Equity (x)
- 0.63x
- Interest Coverage (x)
- 29.30x
- 0.83x
- Revenue Growth %
- 26.36%
- Operating Profit Growth %
- 41.94%
- Net Profit Growth %
- 22.54%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 3.65
- Book Value (₹)
- 8.75
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.07
- Operating Margin %
- 36.29%
- Net Margin %
- 21.74%
- ROE %
- 52.62%
- ROCE %
- 46.63%
- 24.37%
- Debtor Days
- 154
- Inventory Days
- 5
- Payable Days
- 394
- -234
- Debt to Equity (x)
- 0.83x
- Interest Coverage (x)
- 10.24x
- 1.38x
- Revenue Growth %
- 24.55%
- Operating Profit Growth %
- 31.24%
- Net Profit Growth %
- 16.94%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 0.39
- Book Value (₹)
- 21.89
- Dividend per Share (₹)
- 0.05
- Cash EPS (₹)
- 0.75
- Operating Margin %
- 16.22%
- Net Margin %
- 5.60%
- ROE %
- 2.77%
- ROCE %
- 6.41%
- 1.99%
- Debtor Days
- 446
- Inventory Days
- 12
- Payable Days
- 255
- 203
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- 2.07x
- 6.43x
- Revenue Growth %
- -42.06%
- Operating Profit Growth %
- -65.50%
- Net Profit Growth %
- -85.09%
- -89.31%
- P/E (x)
- 80.18x
- P/B (x)
- 1.43x
- Dividend Yield %
- 0.16%
- 19.20x
Mar 2025
- EPS (₹)
- 0.28
- Book Value (₹)
- 22.18
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.69
- Operating Margin %
- 7.98%
- Net Margin %
- 3.27%
- ROE %
- 1.28%
- ROCE %
- 3.39%
- 1.06%
- Debtor Days
- 422
- Inventory Days
- 13
- Payable Days
- 204
- 231
- Debt to Equity (x)
- 0.20x
- Interest Coverage (x)
- 2.21x
- 4.24x
- Revenue Growth %
- 24.12%
- Operating Profit Growth %
- -15.44%
- Net Profit Growth %
- -27.42%
- -27.41%
- P/E (x)
- 51.96x
- P/B (x)
- 0.66x
- Dividend Yield %
- 0.00%
- 10.82x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Dec 2023